Creating new methods for synthesizing important pharmaceutical compounds using gold catalysis
Development of Asymmetric Cooperative Gold Catalysis and Beyond
This study is looking at new ways to use gold and special helpers to make it easier and faster to create important medicines, which could eventually lead to better treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Santa Barbara NIH-funded |
| Lab location | 1 site (Santa Barbara, United States) |
| Project ID | NIH-11237271 on NIH RePORTER |
What this research studies
This research focuses on developing innovative catalytic systems that utilize gold and specially designed ligands to enhance the efficiency of chemical synthesis. By exploring metal-ligand cooperation, the project aims to create new synthetic methods that can produce bioactive and pharmaceutical compounds more effectively. Patients may benefit indirectly from this research as it could lead to the development of new drugs and therapies. The approach involves rigorous experimentation and validation of new ligand designs to optimize the catalytic processes.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research are individuals with conditions that could be treated by new pharmaceutical agents developed through these advanced synthetic methods.
Not a fit: Patients who are not affected by conditions treatable by the new drugs synthesized through this research may not receive any direct benefit.
Why it matters
Potential benefit: If successful, this research could lead to the creation of more effective and efficient pharmaceutical compounds, improving treatment options for various diseases.
How similar studies have performed: Other research in cooperative catalysis has shown promising results, indicating that this approach has the potential for significant advancements in chemical synthesis.
Where this research is happening
Santa Barbara, United States
- University of California Santa Barbara — Santa Barbara, United States (Active)
Researchers
- Principal investigator: Zhang, Liming — University of California Santa Barbara
- Study coordinator: Zhang, Liming
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.